Intensive Care Medicine

, Volume 30, Issue 5, pp 804–810 | Cite as

Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults

  • Salmaan Kanji
  • Avinder Singh
  • Michael Tierney
  • Hilary Meggison
  • Lauralyn McIntyre
  • Paul C. Hebert



Aggressive glycemic control improves mortality and morbidity in critically ill adults, however implementation of such a strategy can be logistically difficult. This study evaluates the efficiency and safety of a nurse-managed insulin protocol in critically ill adults.


Combined retrospective-prospective before-after cohort study.


Twenty-one bed, medical/surgical ICU in a tertiary care hospital.


Two cohorts of 50 consecutive ICU patients requiring insulin infusions.


Patients in the control cohort received insulin infusions titrated according to target blood glucose ranges and sliding scales at the physician’s discretion. Patients in the interventional cohort received an insulin infusion adjusted using a standardized protocol targeting a blood glucose of 4.5–6.1 mmol/l (81–110 mg/dl).

Measurements and main results

Efficiency was measured by comparing the time to reach, and the time spent within, the target range between cohorts. Safety was assessed by comparing the incidence of severe hypoglycemia, the frequency of rescue dextrose administration and the cumulative time that the infusion was held for hypoglycemia between cohorts. Patients in the interventional cohort reached their target more rapidly (11.3±7.9 vs 16.4±12.6 h; p=0.028) and maintained their blood glucose within the target range longer (11.5±3.7 vs 7.1±5.0 h/day; p<0.001) than controls. The standardized protocol yielded a four-fold reduction in the incidence of severe hypoglycemia (4 vs 16%; p=0.046) and reduced the median frequency of dextrose rescue therapy (0 [0–0.91] vs 0.17 [0–1.2] episodes/patient per day; p=0.01) as compared to controls.


Standardization of intensive insulin therapy improves the efficiency and safety of glycemic control in critically ill adults.


Insulin Critical illness Protocol Hyperglycemia Safety Intensive care unit 


  1. 1.
    Vincent JL, Abraham E, Annane D, Bernard G, Rivers E, Van den Berghe G (2002) Reducing mortality in sepsis: new directions. Crit Care 6:S1–S18CrossRefGoogle Scholar
  2. 2.
    Montori VM, Bistrian BR, McMahon MM (2002) Hyperglycemia in acutely ill medical patients. JAMA 288:2167–2169CrossRefPubMedGoogle Scholar
  3. 3.
    Van den Berghe G (2001) Molecular biology: a timely tool for further unraveling the “diabetes of stress”. Crit Care Med 29:910–911PubMedGoogle Scholar
  4. 4.
    Van den Berghe G (2002) Dynamic neuroendocrine responses to critical illness. Front Neuroendocrinol 23:370–391CrossRefPubMedGoogle Scholar
  5. 5.
    Mesotten D, Van den Berghe (2003) Clinical potential of insulin therapy in critically ill patients. Drugs 63:625–636Google Scholar
  6. 6.
    Mesotten D, Delhanty PJD, Vanderhoydonc F, Hardman KV, Weekers F, Baxter RC, Van den Berghe G (2002) Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Metab 87:5516–5523CrossRefPubMedGoogle Scholar
  7. 7.
    McCowen KC, Ling PR, Ciccarone A, Mao Y, Chow JC, Bistrian BR, Smith RJ (2001) Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade. Crit Care Med 29:839–846Google Scholar
  8. 8.
    Finney SJ, Zekveld C, Elia A, Evans TW (2003) Glucose control and mortality in critically ill patients. JAMA 290:2041–2047CrossRefPubMedGoogle Scholar
  9. 9.
    Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367PubMedGoogle Scholar
  10. 10.
    Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P (2003) Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31:359–366PubMedGoogle Scholar
  11. 11.
    Meade MO, Ely EW (2002) Protocols to improve the care of critically ill pediatric and adult patients. JAMA 288:2601–2603PubMedGoogle Scholar
  12. 12.
    Ober KP (1997) Alterations in fuel metabolism in critical illness: hypoglycemia. In: Ober KP (ed) Endocrinology of critical disease. Humana Press, Totowa, NJ, pp 211–231Google Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Salmaan Kanji
    • 1
    • 4
  • Avinder Singh
    • 1
  • Michael Tierney
    • 1
  • Hilary Meggison
    • 2
    • 3
  • Lauralyn McIntyre
    • 2
    • 4
  • Paul C. Hebert
    • 2
    • 4
  1. 1.Department of Pharmacy, Ottawa HospitalGeneral CampusOttawaCanada
  2. 2.Department of Critical Care, Ottawa HospitalGeneral CampusOttawaCanada
  3. 3.Department of Endocrinology, Ottawa HospitalGeneral CampusOttawaCanada
  4. 4.The Ottawa Health Research InstituteOttawa

Personalised recommendations